Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

Viard Jp(Hôpital Necker-Enfants Malades), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Josep M. Gatell(Hospital Clínic de Barcelona), M Losso(Hospital Ramos Mejía), Amanda Mocroft(University of Copenhagen), Brygida Knysz(Wroclaw Medical University), C Pedersen(Sennheiser (Germany)), J.C. Souberbielle(Hôpital Necker-Enfants Malades), J. R. Bogner, Ole Kirk(University of Copenhagen)
Journal of the International AIDS Society
November 1, 2010
10.1186/1758-2652-13-s4-o43
Cited by 15

Related Papers

Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987